Screener
Crinetics Pharmaceuticals CRNX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
FAQ
- What is Crinetics Pharmaceuticals's operating lease ROU assets?
- Crinetics Pharmaceuticals (CRNX) reported operating lease ROU assets of 8.6% in Q1 2026.
- How has Crinetics Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Crinetics Pharmaceuticals's operating lease ROU assets decreased by 100.0% year-over-year, from 4,269,400,000% to 8.6%.
- What is the long-term trend for Crinetics Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's operating lease ROU assets has grown at a -96.7% compound annual growth rate (CAGR), from 223,200,000% to 8.6%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Crinetics Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude